Nektar Therapeutics
NKTR
#4911
Rank
โ‚ฌ1.78 B
Marketcap
52,29ย โ‚ฌ
Share price
-1.81%
Change (1 day)
4.11%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -โ‚ฌ0.14 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ54.58 Million. In 2025 the company made an earning of -โ‚ฌ0.14 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.14 Billion-3.76%
2025 -โ‚ฌ0.14 Billion30.44%
2024 -โ‚ฌ0.11 Billion-56.85%
2023 -โ‚ฌ0.25 Billion-24.31%
2022 -โ‚ฌ0.33 Billion-30.25%
2021 -โ‚ฌ0.47 Billion17.87%
2020 -โ‚ฌ0.4 Billion0.88%
2019 -โ‚ฌ0.39 Billion-164.46%
2018 โ‚ฌ0.60 B-810.61%
2017 -โ‚ฌ84.71 Million-37.06%
2016 -โ‚ฌ0.14 Billion89.22%
2015 -โ‚ฌ71.12 Million48.22%
2014 -โ‚ฌ47.99 Million-65.93%
2013 -โ‚ฌ0.15 Billion-6.81%
2012 -โ‚ฌ0.16 Billion28.95%
2011 -โ‚ฌ0.12 Billion258.8%
2010 -โ‚ฌ32.67 Million-63.94%
2009 -โ‚ฌ90.61 Million-392.45%
2008 โ‚ฌ30.98 M-211.74%
2007 -โ‚ฌ27.73 Million-79.57%
2006 -โ‚ฌ0.14 Billion-16.9%
2005 -โ‚ฌ0.17 Billion81.53%
2004 -โ‚ฌ89.97 Million54.19%
2003 -โ‚ฌ58.35 Million-33.87%
2002 -โ‚ฌ88.24 Million-9.6%
2001 -โ‚ฌ97.6 Million73.39%
2000 -โ‚ฌ56.29 Million108.9%
1999 -โ‚ฌ26.95 Million39.48%
1998 -โ‚ฌ19.32 Million60.02%
1997 -โ‚ฌ12.08 Million18.05%
1996 -โ‚ฌ10.23 Million31.82%
1995 -โ‚ฌ7.76 Million57.14%
1994 -โ‚ฌ4.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.10 B-17,216.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ6.08 B-4,611.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ9.06 B-6,818.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.43 Billion 215.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.77 B-5,122.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.63 B-9,460.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚ฌ6.59 M-104.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.20 B-254.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland